Antineoplastic drugs including those withmanufacturers’ safe handling guidance (MSHG)
decitabine to ifsofamide
http://www.cdc.gov/niosh/docs/2014-138/pdfs/2014-138_v3.pdf

Drug	AHFS classification		MSHG		Reason for listing		Links
decitabine	10:00 antineoplastic agents		yes		FDA Pregnancy Category D		DailyMed; Drugbank
degarelix		10:00 antineoplastic agents		FDA Pregnancy Category X		DailyMed; Drugbank
docetaxel	10:00 antineoplastic agents		yes		FDA Pregnancy Category D		DailyMed; DrugBank
doxorubicin	10:00 antineoplastic agents		yes		IARC Group 2A carcinogen; FDA Pregnancy Category D		DailyMed; DrugBank
epirubicin	10:00 antineoplastic agents		yes		FDA Pregnancy Category D		DailyMed; Drugbank
eribulin		10:00 antineoplastic agents		FDA Pregnancy Category D		DailyMed; DrugBank
erlotinib		10:00 antineoplastic agents		FDA Pregnancy Category D		DailyMed; DrugBank
estramustine	10:00 antineoplastic agents		yes		FDA Pregnancy Category X		DailyMed; Drugbank
etoposide	10:00 antineoplastic agents		yes		IARC Group 1 carcinogen; FDA Pregnancy Category D		DailyMed; DrugBank
everolimus	10:00 antineoplastic agents		yes		FDA Pregnancy Category D		DailyMed; Drugbank
exemestane		10:00 antineoplastic agents		FDA Pregnancy Category X		DailyMed; DrugBank
floxuridine	10:00 antineoplastic agents		yes		FDA Pregnancy Category D		DailyMed; DrugBank
fludarabine	10:00 antineoplastic agents		yes		FDA Pregnancy Category D		DailyMed; DrugBank
fluorouracil	10:00 antineoplastic agents		yes		FDA Pregnancy Category D		DailyMed; DrugBank
flutamide		10:00 antineoplastic agents		Indicated only for men; FDA Pregnancy Category D		DailyMed; DrugBank
fulvestrant		10:00 antineoplastic agents		FDA Pregnancy Category D		DailyMed; DrugBank
gemcitabine	10:00 antineoplastic agents		yes		FDA Pregnancy Category D		DailyMed; DrugBank
gemtuzumab ozogamicin	10:00 antineoplastic agents		yes		FDA Pregnancy Category D		DailyMed; DrugBank
goserelin		10:00 antineoplastic agents		FDA Pregnancy Category X		DailyMed; Drugbank
hydroxyurea	10:00 antineoplastic agents		yes		Special warning on handling bottles and capsules FDA Pregnancy Category D		DailyMed; DrugBank
idarubicin	10:00 antineoplastic agents		yes		FDA Pregnancy Category D		DailyMed; DrugBank
ifosfamide	10:00 antineoplastic agents		yes		FDA Pregnancy Category D		DailyMed; DrugBank